Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rizatriptan

Known as: rizatriptan [Chemical/Ingredient], Rizatriptán, N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine 
National Institutes of Health

Related topics

Related topics

13 relations
Angina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Drug AllergyRizatriptan Sulfate
Expand

Narrower (4)

MK 0462Rizatriptan benzoaterizatriptan 10 MG Disintegrating Oral Tabletrizatriptan 10 MG Oral Tablet

Broader (3)

Serotonin AgonistsTriazolesTryptamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine… Expand
Highly Cited
2014
Highly Cited
2014
Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks
In 459 migraine attacks, information provided to patients (from negative to neutral to positive) modified placebo and medication… Expand
Highly Cited
2008
Highly Cited
2008
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
Objective: To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Review
2004
Review
2004
Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents
Objective: To review evidence on the pharmacologic treatment of the child with migraine headache. Methods: The authors reviewed… Expand
  • table 1
  • table 2
  • table 3
Review
2003
Review
2003
Migraine Headache Recurrence: Relationship to Clinical, Pharmacological, and Pharmacokinetic Properties of Triptans
Background and Objectives.—Triptan use is associated with headache recurrence, and this has been cited as an important reason for… Expand
Review
2002
Review
2002
Triptans (Serotonin, 5-HT1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials
The triptans, selective serotonin 5-HT1B/1D agonists, are very effective acute migraine drugs. Soon, seven different triptans… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Highly Cited
2001
Highly Cited
2001
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
BACKGROUND The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine
Rizatriptan is a potent, oral, 5‐HT1B/1D agonist with more rapid absorption and higher bioavailability than oral sumatriptan. It… Expand
Highly Cited
1997
Highly Cited
1997
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
These studies in anaesthetised rats showed, using intravital microscopy, that the novel anti-migraine agent, rizatriptan… Expand
Highly Cited
1996
Highly Cited
1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
BACKGROUND Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE